Skip to main content
. 2017 Nov 21;7:15918. doi: 10.1038/s41598-017-15139-5

Figure 7.

Figure 7

Inhibition of xenograft CRC tumor growth and manifestation of EMT by stable knockdown of USP47. BALB/C nude mice were injected subcutaneously with shControl- or shUSP47-transfected DLD-1 cells (N = 5 mice/group) and sacrificed after 4 weeks. (a) Representative images of xenografts derived from shCtrl- and shUSP47-transfected DLD-1 cells. (b,c) Changes in the volume (b) and the weight (c) of xenograft tumors. Results are representative of three independent experiments. (d) Protein expression levels of USP47 and EMT markers in xenografts derived from USP47-deficient and control DLD-1 cells were examined by Western blot analysis. (e) Representative immunofluorescence images of tumors derived from shControl- or shUSP47-treated DLD-1 cells. Paraffin sections of the tumors were stained for USP47, PCNA, E-cadherin, N-cadherin, vimentin, and Snail. Scale bar = 100 μm. Statistical significance was assessed using the two-sided Student’s t-test; *P < 0.05, **P < 0.01, and ***P < 0.001.